I read Dr Sharma et al.'s paper (J Perinatol 26: 342-347; doi: 10.1038) and found it to be very interesting and in general a nice and detailed study of the variance in acquired neonatal bowel disease presentations across gestation ages. However, I have three points to raise about their analysis and conclusions.
First, in Figure 1 , an r-value of 0.122 is not a particularly satisfying fit and I suspect the problem there is that the relationship is not truly linear. It is not unusual to get significance when one plots a linear fit to what is actually a skewed hyperbolic function with the dominant tail being aligned with the linear regression. However, more than that, they had 48 infants in the 23-26 weeks category in Table 3 , but only five of them are apparent in Figure 1 . This is a substantial amount of drop out for something that is generally easy to extract from the record. I suspect that the majority of infants in the EP category perforated in the first 2 weeks of life, but I will come back to this point.
Second, the probability curves in Figure 2 are a nice idea, but the use of this methodology makes the assumption that there is a continuity of gastrointestinal disease between EP and all other categories of infants. I am not sure what they mean if that assumption is invalid.
Third, only 29% of the 23-26 weeks gestation infants had intramural gas (read pneumatosis); 54% of them had pneumoperitoneum; whereas 77% had ileus. In short, two-thirds of the EP subgroup potentially met criterion for spontaneous intestinal perforation (SIP). This disease has been well delineated as being different from necrotizing enterocolitis and, to get back to my first point, they most commonly perforate in the first 2 weeks of life. We thank Dr Gordon for his interest in our paper, and for his thoughtful comments.
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The following is our response to his comments: 1. Although we do not disagree that the relationship depicted in Figure 1 (see published article) between the day of onset of necrotizing enterocolitis (NEC) and postmenstrual age is not the clearest demonstration of a linear relationship, all analyses including following log transformation (Figure 1 , given here) demonstrate an inverse relationship between the day of onset of NEC and either postmenstrual age or gestational age. This finding agrees with Dr Gordon's comment that the relationship is not truly linear (Figure 2 , given here) and with other reports in the literature. We reviewed plausible physiological explanations for this observation in our discussion.
None of the 48 infants in the extremely premature (EP) group (gestational age, 23 to 26 weeks) were lost to follow-up. The x axis in this figure refers to postmenstrual age (gestational age plus postnatal age). The onset of NEC among EP infants ranged from 0 to 45 days (mean 22 days, see Table 1 in published article) and hence only five (9.6%) infants developed NEC at a postmenstrual age between 23 and 26 weeks.
2. Figure 2 in published article graphically depicts smoothed probability curves for different signs and symptoms of NEC as a function of gestational age as a continuous variable and stands on its own. We feel that it provides an excellent visual summary of how the clinical presentation of NEC changes with advancing gestational age.
3. We feel that one of the major strengths of our paper is that only infants with NEC that was confirmed by radiologic, pathologic and/or post-mortem findings were included. Of 69 infants with pneumoperitoneum, histopathological findings confirming NEC were available for 55, and a clinical diagnosis of NEC was made in the remaining 14 infants secondary to a combination of portal venous gas, 1 intramural gas, and frequent bloody mucoid stools in association with other medical derangements characteristic of NEC. 2, 3 Our study excluded infants with a pathologic diagnosis of spontaneous intestinal perforation (SIP) or with an uncertain diagnosis. Instead, we believe that our findings call into doubt the diagnosis of SIP in an infant who presents with only pneumoperitoneum and abdominal discoloration in the absence of pathologic and/or post-mortem confirmatory evidence of SIP.
We have observed from our own cases of confirmed SIP 3, 4 that the risk factors, the histopathological findings, the clinical presentation and the outcome of NEC and SIP differ. Whether NEC and SIP are two different disease processes or represent different clinicopathological expressions of the same disease process is still open to question. We appreciate Dr Gordon's questions and look forward to further discussion after we have published our experience 4 with the risk factors and outcome of histopathologically confirmed cases of SIP. 
